Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis (2020)

First Author: Rajoli R
Attributed to:  MICA: New combination therapy against MDR TB targeting the respiratory chain funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bcp.14619

PubMed Identifier: 33085781

Publication URI: http://europepmc.org/abstract/MED/33085781

Type: Journal Article/Review

Parent Publication: British Journal of Clinical Pharmacology

Issue: 4

ISSN: 0306-5251